choloxin
Pharmaranks rates Choloxin 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Choloxin (Dextrothyroxine Sodium) is a medication used to treat Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias.
Dextrothyroxine Sodium · by Abbvie
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Dextrothyroxine Sodium
- Form
- Tablet
- Strength
- Dextrothyroxine Sodium 1MG · Dextrothyroxine Sodium 2MG · Dextrothyroxine Sodium 4MG · Dextrothyroxine Sodium 6MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Abbvie
- FDA application
- NDA012302
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Choloxin treat?
- Choloxin (Dextrothyroxine Sodium) may be used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Choloxin rated?
- pharmaranks gives Choloxin a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Choloxin?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Choloxin. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Choloxin?
- Choloxin is marketed by Abbvie. You can see Abbvie's full profile, rating, and other products on pharmaranks.
- Is Choloxin a brand-name or generic drug?
- Choloxin is a brand-name product with the active ingredient Dextrothyroxine Sodium.
- Is Choloxin available over the counter?
- No. Choloxin is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Choloxin come in?
- Choloxin is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Choloxin FDA-registered?
- Choloxin is on record with the U.S. FDA under application number NDA012302. You can verify this on its official FDA label.
- Has Choloxin been recalled by the FDA?
- Choloxin has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Choloxin safe?
- There's no single safe-or-not verdict. pharmaranks gives Choloxin a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about DEXTROTHYROXINE SODIUM
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 2 reports naming DEXTROTHYROXINE SODIUM — the active ingredient in Choloxin, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- respiratory tract infection2 reports
- adenocarcinoma1 reports
- asthma1 reports
- breath sounds abnormal1 reports
- dyspnoea1 reports
- emphysema1 reports
- eosinophilia1 reports
- full blood count abnormal1 reports
Read these as a signal, not a rate. A report does not mean DEXTROTHYROXINE SODIUM caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
amlodipine besylate
Amlodipine Besylate
juxtapid
Lomitapide Mesylate
katerzia
Amlodipine Benzoate
norvasc
Amlodipine Besylate
praluent
Alirocumab
repatha
Evolocumab
Compare Choloxin head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
choloxin
72/100